Company News - VC and PE investment business - Medical and health professional investment - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 09 - 28

Multi-List Recognition, Unwavering Dedication! Efung Capital's Multiple Industry Honors Revealed | Efung Hornor

Recently, Efung Capital has successively received multiple industry honors from Entrepreneur (创业邦), China Fund News (中国基金报), 36Kr, and Haoyue (浩悦); CEO Mr. Zhu Pai was named to 36Kr's Top 20 Chinese Life Science Industry Investors. (Listed in order of announcement date.)【Entrepreneur (创业邦)】 For the sixth consecutive year, the "Most Admired Venture Capital Institutions" selection was launched. It pioneered the "peer review" mechanism in the industry, handing important judging power to investors on the market frontline, observing institutions' professional ca...

浏览次数：8

查看详情>>

发布时间: 2026 - 09 - 23

Wang Xingxing of Unitree Leads Newcomers on Fortune China 40 Under 40

Today, Fortune (Chinese edition) officially released the "2026 Fortune China 40 Under 40" list. Zhu Pai, CEO of Efung Capital, was honored to be included.Since its establishment in 2011, the list has continued to spotlight China's younger generation of innovators and value creators. Among past honorees, names such as Pony Ma, Chairman of the Board and CEO of Tencent; Richard Liu, Chairman of the Board of JD.com;and Liang Wenfeng, founder of DeepSeek, have since profoundly influenced Chinese business.Among this year's 40 honorees, business elites including Wang Xingxing, found...

浏览次数：11

查看详情>>

发布时间: 2026 - 09 - 21

Together Embarking on a New Journey for the 15th Five-Year Plan | Efung Capital and Its Portfolio Companies Appear at the 2026 Shenzhen High-Performance Medical Device Exhibition

September 21–23, the 2026 Shenzhen International High-Performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition grandly opened at Hall 1 of the Shenzhen Convention and Exhibition Center (Futian).This exhibition is hosted by the Shenzhen Medical Device Industry Association and the National High-Performance Medical Device Innovation Center, with the Shenzhen Municipal Development and Reform Commission (Shenzhen Pharmaceutical and Medical Device Industry Office), the Shenzhen Municipal Health Commission, and the Shenzhen Municipal Healthcare Security Bureau as supporting unit...

浏览次数：12

查看详情>>

发布时间: 2026 - 09 - 18

3.5 Trillion Yuan! China's 2030 Goal for the Pharmaceutical Industry

China's Ministry of Industry and Information Technology, together with nine other government departments, recently issued the "15th Five-Year Plan for the Development of the Pharmaceutical Industry."The plan proposes that by 2030, China's biopharmaceutical R&D and application shall rank among the world's leading positions, the effectiveness of innovation-driven development shall be fully unleashed, and systematic breakthroughs shall be achieved in key core technologies in priority fields. Core competitiveness and international influence shall rise substantially. T...

浏览次数：7

查看详情>>